The quantities and cytokine production capability of CD8+ T cells specific for IAV HA533-541, NP147-155, and RSV M282-90 were assessed three weeks after the secondary infection and compared to control mice that did not receive the challenge (Fig. 6A). This evidence concerns the gene CD8A and infection.